Bill · S. 3076· Senate(119-S-3076)
Nitazene Control Act
- Introduced
- 10/30/2025
- Last activity
- 10/30/2025 — Read twice and referred to the Committee on the Judiciary.
- Sponsored by
- David McCormick
- Cosponsors
- - 4 - 3
- Introduced
- In Committee
What this bill would do
The Nitazene Control Act aims to amend the Controlled Substances Act to permanently schedule 2-benzylbenzimidazole-opioids, commonly known as nitazenes. These synthetic opioids are noted for their high potency, sometimes exceeding that of fentanyl, and their contribution to fatal poisonings. The bill seeks to implement a class-wide permanent scheduling of these substances. This measure is intended to address the emergence of new analogs and streamline enforcement efforts. By doing so, the legislation aims to protect public health.
Yes· 3 of 12
Does this do more about addiction and overdose deaths?+8
The bill permanently schedules nitazenes under schedule I to combat synthetic opioid abuse and protect public health.
Would children be better off under this?+6
Protecting communities from lethal synthetic opioids benefits youth and families by reducing overdose risks.
Would people in their twenties and thirties be better off under this?+6
Young adults face high risks from illicit synthetic opioids, making enforcement beneficial for their demographic safety.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Public Health Protection: The bill seeks to protect public health by addressing the proliferation of new analogs and the emergence of nitazenes and related compounds in the illicit drug supply (Section 2).
-
Streamlined Enforcement: A class-wide permanent scheduling is intended to streamline enforcement against these substances (Section 2).
-
Addressing High-Potency Risks: The legislation targets 2-benzylbenzimidazole opioids which exhibit significant potency at the mu-opioid receptor, with some substances exceeding the potency of fentanyl (Section 2).
Potential Negative Impacts for People
- Research Restrictions: The bill specifies that nothing in the subsection shall be construed to authorize the initiation of new research using these opioids without proper registration and scheduling compliance (Section 3(c)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Children+6Good For Young Adults+6Good For Middle Aged+5Good For Low Income Households+4Good For Rural Residents+4Good For Urban Residents+4Good For Men+3Good For Middle Class Households+3Good For Seniors+3Good For Women+3
- Healthcare
- Improves Opioid Crisis Response+8
- Governance And Ideology
- Increases Federal Power+2
- 9/15/2026
- 1 Cosponsor added.
- 10/30/2025
- Read twice and referred to the Committee on the Judiciary.
- 6 Cosponsors added.
- Introduced in Senate
Ruben GallegoDemocrat · Arizona
Cindy Hyde-SmithRepublican · Mississippi
Ashley MoodyRepublican · Florida
Pete RickettsRepublican · Nebraska
Jeanne ShaheenDemocrat · New Hampshire
Elissa SlotkinDemocrat · Michigan
Eric SchmittRepublican · Missouri